What is the recommended follow-up schedule after post-exposure rabies prophylaxis (PERP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Follow-up Schedule After Post-Exposure Rabies Prophylaxis (PERP)

For previously unvaccinated individuals who receive post-exposure rabies prophylaxis, the recommended follow-up schedule includes vaccine doses on days 0,3,7, and 14, with no routine serologic testing required after completion of the regimen. 1, 2

Standard Follow-up Schedule

Previously Unvaccinated Individuals

  • The 4-dose vaccination regimen should be administered intramuscularly on days 0,3,7, and 14, with day 0 being the day the first dose is administered 1, 2
  • Human rabies immune globulin (HRIG) is administered only once on day 0 at the time PEP is initiated 1
  • If HRIG was not administered when vaccination began on day 0, it can be administered up to and including day 7 of the PEP series 1, 2
  • No routine serologic testing is necessary for healthy individuals after completion of PEP 1

Previously Vaccinated Individuals

  • Only 2 vaccine doses are required, administered on days 0 and 3 1, 2
  • HRIG should not be administered to previously vaccinated persons 1
  • No serologic testing is required after completion of the 2-dose regimen 1

Special Populations

Immunocompromised Individuals

  • Require a 5-dose vaccination regimen on days 0,3,7,14, and 28 1, 2
  • HRIG is administered once on day 0 1
  • Serologic testing is recommended 1-2 weeks after completion of the vaccination series to confirm adequate antibody response 1, 2

Managing Deviations from the Schedule

  • Minor delays of a few days for individual doses are generally not significant 1
  • For minor deviations, vaccination can be resumed as though the patient were on schedule 1
  • Example: If a patient misses the day 7 dose and presents on day 10, the day 7 dose should be administered that day and the schedule resumed, with the remaining dose given on day 17 1
  • For substantial deviations from the schedule, immune status should be assessed by performing serologic testing 7-14 days after administration of the final dose 1

Post-Completion Monitoring

  • No routine post-vaccination serologic testing is necessary for healthy individuals completing the recommended PEP regimen 1, 2
  • When titers are obtained (such as in immunocompromised patients), serum specimens collected 1-2 weeks after prophylaxis should completely neutralize challenge virus at least at a 1:5 serum dilution by the rapid fluorescent focus inhibition test (RFFIT) 1
  • No additional follow-up visits are required after completion of the vaccine series unless the patient develops concerning symptoms 2

Common Pitfalls and Caveats

  • The gluteal area should never be used for vaccine administration as it may result in diminished immune response 1, 2
  • Administering more than the recommended dose of HRIG might partially suppress active production of rabies virus antibody 1
  • Deviations from the recommended vaccination schedule have been associated with vaccination failure and human mortality 3
  • The 4-dose schedule is only for immunocompetent individuals; immunocompromised patients still require the full 5-dose regimen 2, 4

When administered properly and according to schedule, rabies PEP is nearly 100% effective in preventing human rabies 2, 4. The follow-up schedule is designed to ensure adequate antibody response while minimizing unnecessary doses and clinic visits.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Current Rabies Post-Exposure Prophylaxis Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.